Evidence map›Paper›PMID 32945993›Full record

ArticleJournal of assisted reproduction and genetics2020

Rare genetic variants suggest dysregulation of signaling pathways in low- and high-risk patients developing severe ovarian hyperstimulation syndrome.

L Borgwardt, K W Olsen, M Rossing, R Borup Helweg-Larsen, M Toftager, A Pinborg, J Bogstad, K Løssl, A Zedeler, M L Grøndahl

Open access · greenAbstract read
In one paragraph

Article in Journal of assisted reproduction and genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

L BorgwardtCentre for Genomic Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark. Line.gutte.borgwardt@regionh.dk.ORCID http://orcid.org/0000-0003-1719-9856
K W OlsenDepartment of Obstetrics and Gynaecology, Fertility Clinic, Copenhagen University Hospital, Herlev, Denmark.
M RossingCentre for Genomic Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
R Borup Helweg-LarsenFunctional Genomics and Reproductive Health Group, Faculty of Health and Medical Sciences- Copenhagen University, Copenhagen, Denmark.
M ToftagerDepartment of Obstetrics and Gynaecology, Fertility Clinic, Copenhagen University Hospital, Hvidovre, Denmark.
A PinborgFertility Clinic, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
J BogstadDepartment of Obstetrics and Gynaecology, Fertility Clinic, Copenhagen University Hospital, Hvidovre, Denmark.
K LøsslDepartment of Obstetrics and Gynaecology, Fertility Clinic, Copenhagen University Hospital, Hvidovre, Denmark.
A ZedelerDepartment of Obstetrics and Gynaecology, Fertility Clinic, Copenhagen University Hospital, Hvidovre, Denmark.
M L GrøndahlDepartment of Obstetrics and Gynaecology, Fertility Clinic, Copenhagen University Hospital, Herlev, Denmark.
Copenhagen University Hospital · DKUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate if rare gene variants in women with severe ovarian hyperstimulation syndrome (OHSS) provide clues to the mechanisms involved in the syndrome.

methodsAmong participants in a prospective randomized study (Toftager et al. 2016), six women with predicted low and six women with predicted high risk of OHSS developing severe OHSS (grades 4 and 5, Golan classification) were selected. In the same cohort, six plus six matched controls developing no signs of OHSS (Golan grade 0) were selected. Whole-exome sequencing was performed. Analysis using a predefined in silico OHSS gene panel, variant filtering, and pathway analyses was done.

resultsWe found no convincing monogenetic association with the development of OHSS using the in silico gene panel. Pathway analysis of OHSS variant lists showed substantial overlap in highly enriched top pathways (p value range p < 0.0001 and p > 9.8E-17) between the low- and high-risk group developing severe OHSS, i.e., "the integrin-linked kinase (ILK) signaling pathway" and the "axonal guidance signaling pathway," both being connected to vasoactive endothelial growth factor (VEGF) and endothelial function.

conclusionRare variants in OHSS cases with two distinct risk profiles enrich the same signaling pathways linked to VEGF and endothelial function. Clarification of the mechanism as well as potentially defining genetic predisposition of the high vascular permeability is important for future targeted treatment and prevention of OHSS; the potential roles of ILK signaling and the axonal guidance signaling need to be validated by functional studies.

Indexed as

Fertilization in VitroAdultChorionic GonadotropinCohort StudiesEndothelial Growth FactorsExome SequencingFemaleHumansOvarian Hyperstimulation SyndromeProspective StudiesProtein Serine-Threonine KinasesScaffold Protein ILKSignal TransductionVascular Endothelial Growth Factor AChorionic GonadotropinEndothelial Growth FactorsProtein Serine-Threonine KinasesScaffold Protein ILKVascular Endothelial Growth Factor AVEGFA protein, humanAxonal guidance signalingILK signaling pathwayOvarian hyperstimulation syndromePathway analyses

Identifiers

PMID32945993
PMCPMC7642034
OpenAlexW3087083356

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.